Figure 4

Correlation between neutralizing activity against antibody titers and wild-type and beta variant. (a) Wild-type vs. anti-S-IgG levels. (b) Beta variant vs. anti-S-IgG levels. (c) Wild-type vs. anti-N-IgG levels. (d) Beta variant vs. anti-N-IgG levels.